Evidence map›Paper›PMID 36838765›Full record

ArticleMolecules (Basel, Switzerland)2023

A Synergetic Strategy for Brand Characterization of Colla Corii Asini (Ejiao) by LIBS and NIR Combined with Partial Least Squares Discriminant Analysis.

Ziyi Xia, Xiaoqing Che, Lei Ye, Na Zhao, Dongxiao Guo, Yanfang Peng, Yongqiang Lin, Xiaona Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 13 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ziyi XiaCollege of Integrated Traditional Chinese and Western Medicine, Binzhou Medical University, Yantai 264003, China.
Xiaoqing CheShandong Runzhong Pharmaceutical Co., Ltd., Yantai 256603, China.
Lei YeCollege of Integrated Traditional Chinese and Western Medicine, Binzhou Medical University, Yantai 264003, China.
Na ZhaoKey Laboratory of Xinjiang Phytomedicine Resources and Utilization in Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832002, China.
Dongxiao GuoShandong Institute of Food and Drug Inspection, Jinan 250101, China.
Yanfang PengPharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China.
Yongqiang LinShandong Institute of Food and Drug Inspection, Jinan 250101, China.ORCID 0000-0001-9290-7184
Xiaona LiuCollege of Integrated Traditional Chinese and Western Medicine, Binzhou Medical University, Yantai 264003, China.ORCID 0000-0001-8934-056X
Binzhou Medical University · CNShandong Institute of Food and Drug Inspection · CNHubei University of Chinese Medicine · CNShihezi University · CN

Funding

National Natural Science Foundation of China 81903796
6 · The paper itself

Abstract

A synergetic strategy was proposed to address the critical issue in the brand characterization of

Indexed as

Medicine, Chinese TraditionalSpectroscopy, Near-InfraredDiscriminant AnalysisGelatinLeast-Squares Analysiscolla corii asiniGelatinbrand characterizationColla Corii Asinidata fusionlaser-induced breakdown spectroscopynear-infrared spectroscopy

Identifiers

PMID36838765
PMCPMC9965801
OpenAlexW4320732425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.